Brief: Oxford Biomedica Expects FY2026 Revenues To Reach £220-£240 Mln

Oxford BioMedica

14/08/2025 17:29

Aug 14 (Reuters) - Oxford BioMedica PLC OXB.L:

OXFORD BIOMEDICA PLC: FY2026 REVENUES EXPECTED TO REACH BETWEEN £220-240 MILLION

OXFORD BIOMEDICA PLC: 2027 AND 2028 EXPECTED REVENUE GROWTH OF 25-30% YEAR-ON-YEAR

OXFORD BIOMEDICA : EQUITY RAISE OF ABOUT £60 MILLION THROUGH A PLACING CONDUCTED THROUGH AN ACCELERATED BOOK BUILD

OXFORD BIOMEDICA PLC: FY2025 GUIDANCE UNCHANGED

OXFORD BIOMEDICA PLC: LONG-TERM POTENTIAL TO APPROACH OPERATING EBITDA MARGINS OF C.30% OVER A FIVE-TO-SIX YEAR PERIOD

Source text: ID:nRSN4133Va

Further company coverage: OXB.L

 ((((Reuters.Briefs@thomsonreuters.com));))